NRXP Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NRXP shares is 21, representing 6.05% of the company's common stock.

MORGAN STANLEY, in the last quarter, reduced its stake in NRXP by -50.7% restricting it's holding to 670 shares of worth nearly $24.00K. ADVISOR GROUP HOLDINGS, INC. also lessened -30% of the NRXP shares from its portfolio, reducing its holding to 350 shares of worth $12.00K. UBS GROUP AG also shunned NRXP shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, WEALTHCARE ADVISORY PARTNERS LLC increased its stake in NRXP by 100% in the last quarter. The institutional holder raised its holding to 375 shares having worth more than $13.00K. JANE STREET GROUP, LLC also added 100% more shares of NRXP to its portfolio, raising its holding to 7.15 thousand shares of worth $253.00K. TOWER RESEARCH CAPITAL LLC (TRC) also increased its NRXP shares holding by 100% which brought its holding to 100 shares worth $4.00K.

The insider with the most stakes in NRXP is Javitt Daniel C. , director at the company. Additionally, NRXP stock is highly held by director Hurvitz Chaim and 10 percent owner Polar Asset Management Partners Inc. among others.

Company executives, directors, and other insiders own 23.56% percent of NRx Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which NRXP insiders have sold stock, totaling 0 shares. Insiders that have sold shares include JAVITT JONATHAN C, JAVITT DANIEL C., and BESTHOF ROBERT.

There have been 1 transaction(s) during the past 6-months in which NRx Pharmaceuticals, Inc. insiders have bought stock, totalling 40000 shares

Around 84.63K NRx Pharmaceuticals, Inc. shares are held by insiders, which represents about 23.56% of NRXP stock.

NRXP director, Javitt Daniel C. holds the largest portfolio of the company's shares. NRXP shares owned by Javitt total nearly 9.63 million.

MORGAN STANLEY is the largest institutional owner in NRXP which holds 670 shares worth $24.00K or 0% of the total NRXP shares outstanding followed by WEALTHCARE ADVISORY PARTNERS LLC with ownership of 375 shares representing 0% of the NRXP ownership. JANE STREET GROUP, LLC is the third largest stakeholder with 7.15 thousand shares or 0.02% of the ownership worth more than $253.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NRXP is concerned, it is a stock which is optionable.

Number of NRXP shares short is 682.66K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 12.09M shares of NRXP are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NRXP has 7.94M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NRXP is 4.8.